Neuralink Gets FDA Approval For ‘First-In-Human Clinical Study’

Elon Musk's brain-implant company Neuralink has received the green light from the Food and Drug Administration to commence its "first-in-human clinical study."
What Happened: This milestone achievement for Neuralink comes after a series of setbacks and challenges faced by the company in its pursuit of FDA approval.
See Also: Elon Musk Says He’d Approve Implanting Neuralink…

This story appeared on, 2023-05-26.
The Web's Most Comprehensive Business News Hub. Free to Use →